| CTLA4 |
CTLA4, CD152: Cytotoxic T-lymphocyte protein 4 precursor |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
6.98 |
Evidence |
|
| PECAM1 |
PECAM1: Platelet endothelial cell adhesion molecule precursor |
FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
6.98 |
Evidence |
|
| CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
CTLA4 |
CTLA4, CD152: Cytotoxic T-lymphocyte protein 4 precursor |
6.98 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
CNN1 |
CNN1: Calponin-1 |
6.98 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
CTLA4 |
CTLA4, CD152: Cytotoxic T-lymphocyte protein 4 precursor |
6.98 |
Evidence |
O
|
| ARVCF |
ARVCF: Armadillo repeat protein deleted in velo-cardio-facial syndrome |
HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
6.957 |
Evidence |
|
| KIT |
KIT: Mast/stem cell growth factor receptor precursor |
CAV1 |
CAV1, CAV: Caveolin-1 |
6.937 |
Evidence |
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
FRS2 |
FRS2: Fibroblast growth factor receptor substrate 2 |
6.937 |
Evidence |
|
| RAC2 |
RAC2: Ras-related C3 botulinum toxin substrate 2 precursor |
DGKD |
DGKD, KIAA0145: Diacylglycerol kinase delta |
6.932 |
Evidence |
|
| SMARCA3 |
HLTF, HIP116A, RNF80, SMARCA3, SNF2L3, ZBU1: Helicase-like transcription factor |
RAD18 |
RAD18, RNF73: E3 ubiquitin-protein ligase RAD18 |
6.932 |
Evidence |
|
| PRKAR2A |
PRKAR2A, PKR2, PRKAR2: cAMP-dependent protein kinase type II-alpha regulatory su |
PRKACA |
PRKACA, PKACA: cAMP-dependent protein kinase, alpha-catalytic subunit |
6.932 |
Evidence |
|
| STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
TSHR |
IPI00386365 |
6.92 |
Evidence |
|
| JUNB |
JUNB: Transcription factor jun-B |
EPHA8 |
EPHA8, EEK, KIAA1459: Ephrin type-A receptor 8 precursor |
6.92 |
Evidence |
|
| JUN |
JUN: Transcription factor AP-1 |
EPHA8 |
EPHA8, EEK, KIAA1459: Ephrin type-A receptor 8 precursor |
6.92 |
Evidence |
|
| TGFB1 |
TGFB1, TGFB: Transforming growth factor beta-1 precursor |
SMAD1 |
SMAD1, BSP1, MADH1, MADR1: Mothers against decapentaplegic homolog 1 |
6.92 |
Evidence |
|
| FIGF |
FIGF, VEGFD: Vascular endothelial growth factor D precursor |
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
6.92 |
Evidence |
|
| KCNQ2 |
KCNQ2: Potassium voltage-gated channel subfamily KQT member 2 |
IQGAP1 |
IQGAP1, KIAA0051: Ras GTPase-activating-like protein IQGAP1 |
6.92 |
Evidence |
|
| KLF5 |
KLF5, BTEB2, CKLF, IKLF: Krueppel-like factor 5 |
GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
6.92 |
Evidence |
|
| ACTG1 |
ACTB: Actin, cytoplasmic 1 |
PLCB1 |
PLCB1, KIAA0581: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta- |
6.92 |
Evidence |
|
| ACTG1 |
ACTB: Actin, cytoplasmic 1 |
SNTA1 |
SNTA1, SNT1: Alpha-1-syntrophin |
6.92 |
Evidence |
|
| FXR1 |
FXR1: Fragile X mental retardation syndrome-related protein 1 |
CASKIN2 |
CASKIN2, KIAA1139: Caskin-2 |
6.92 |
Evidence |
|
| RPS6KB1 |
IPI00216132 |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
6.92 |
Evidence |
|
| F10 |
F10: Coagulation factor X precursor |
EPHA1 |
EPHA1, EPH, EPHT, EPHT1: Ephrin type-A receptor 1 precursor |
6.917 |
Evidence |
|
| ARF3 |
ARF3: ADP-ribosylation factor 3 |
ARF1 |
ARF1: ADP-ribosylation factor 1 |
6.912 |
Evidence |
|
| WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
EPHB1 |
EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor |
6.91 |
Evidence |
|
-